View Older Stories View More Recent Stories

Jan 26, 2017 10:01AM AveXis (AVXS) Ramps 11% on Bullish Analyst Call, $100 PT
Jan 26, 2017 09:47AM AveXis (AVXS) PT Raised to $100 at Chardan Capital Markets
Jan 24, 2017 08:29AM La Jolla Pharma (LJPC) a Top Pick at Chardan Capital Markets Into Data
Jan 17, 2017 08:38AM PlacementTracker Publishes 2016 Private Placement Market League Tables
Jan 11, 2017 08:14AM NICE Systems (NICE): Raising PT After Acquisition Closes - Chardan
Jan 9, 2017 06:56AM Alnylam Pharmaceuticals (ALNY) PT Raised 41% at Chardan Capital Markets to $97
Jan 6, 2017 06:39AM Medicines Co. (MDCO): Top Pick for 2017 - Chardan
Jan 6, 2017 05:51AM Chardan Capital Markets Starts Benefitfocus (BNFT) at Buy, $36 PT
Jan 5, 2017 12:56PM Chardan Capital Weighs in on 22nd Century Group (XXII) as FDA Responds to MRTP Application
Jan 5, 2017 07:03AM Microbot Medical (MBOT) to Sell 700K Shares for $3.5M in Direct Offering
Jan 5, 2017 07:00AM Microbot Medical Inc. Announces $3.5 Million Registered Direct Offering
Jan 4, 2017 10:35AM Social Reality (SRAX) Announces $4M Direct Offering
Jan 4, 2017 10:34AM Social Reality Announces Offering for $4 Million
Dec 27, 2016 09:38AM Spinraza Label Suggests AveXis (AVXS) AVXS-101 Should Be The Superior Product - Chardan Capital Markets
Dec 27, 2016 06:32AM GlobalStar (GSAT): FCC Approves TLPS - Chardan Capital Markets
Dec 20, 2016 09:32AM Northwest Biotherapeutics (NWBO) to Sell 28.6M Shares at $0.35/Share
Dec 20, 2016 09:29AM NW BIO ANNOUNCES A REGISTERED DIRECT OFFERING OF $10.0 MILLION WITH INSTITUTIONAL INVESTORS
Dec 20, 2016 07:31AM Chardan Capital Markets Upgrades Clovis Oncology (CLVS) to Neutral
Dec 19, 2016 04:05PM Origo Acquisition Corporation and Aina Le’a, Inc. Agree to Business Combination
Dec 16, 2016 06:24AM Chardan Capital Markets Downgrades iPass Inc. (IPAS) to Neutral
Dec 15, 2016 06:29AM Chardan Capital Markets Upgrades Profire Energy (PFIE) to Buy
Dec 13, 2016 06:33AM Chardan Capital Markets Downgrades Arbutus Biopharma (ABUS) to Neutral; Safety Risk Overwhelms Promising Efficacy
Dec 13, 2016 06:26AM Chardan Capital Markets Starts HealthEquity, Inc (HQY) at Buy
Dec 12, 2016 09:30AM Pre-Open Stock Movers 12/12: (AKAO) (AIQ) (CSOD) Higher; (OPHT) (ALXN) (VIAB) Lower (more...)
Dec 12, 2016 09:00AM PharmaCyte Biotech Secures Funding Opportunity for Pancreatic Cancer Clinical Trial
Dec 12, 2016 06:37AM Regeneron (REGN) Gains Early on Ophthotech Wet AMD Failure
Dec 12, 2016 06:10AM Chardan Capital Markets Downgrades Ophthotech Corp (OPHT) to Neutral
Dec 12, 2016 06:05AM Chardan Capital Markets Upgrades Regeneron Pharma (REGN) to Neutral
Dec 7, 2016 04:52PM Palatin Technologies Closes on $16.5 Million Financing
Dec 6, 2016 09:03AM Chardan Capital Markets Reiterates Buy on Eyegate Pharma (EYEG) Following Study Results
Dec 5, 2016 09:12AM Chardan Capital Markets Reiterates Buy on Vuzix Corp. (VUZI)
Dec 5, 2016 08:30AM Chardan Capital Markets Positive on Alnylam (ALNY) as ASH Data Reinforces Potential for RNAi Across Hemophilia and AIP
Dec 2, 2016 10:05AM Vuzix Announces Closing of $14,500,000 Common Stock Offering
Dec 1, 2016 04:16PM VBL Therapeutics (VBLT) Reports $20M at the Market Offering of Ordinary Shares
Dec 1, 2016 08:21AM Palatin Technologies (PTN) Prices $16.5M Common Stock, Warrants Offering
Dec 1, 2016 08:20AM Palatin Technologies Announces Pricing of Public Offering of Common Stock and Warrants
Nov 30, 2016 04:54PM Palatin Technologies (PTN) Confirms Proposed Offering of Common Stock and Warrants
Nov 30, 2016 04:36PM Palatin Technologies Announces Proposed Public Offering of Common Stock and Warrants
Nov 30, 2016 10:35AM Notable Analyst Rating Changes 11/30: (UNH) (CE) (GS) Upgraded; (GRA) (FCX) (DLTH) Downgraded
Nov 30, 2016 06:33AM Alnylam Pharmaceuticals (ALNY) PT Raised to $89 at Chardan Capital Markets Following Arrowhead's RNAi Program Discontinuations
Nov 30, 2016 06:25AM Chardan Capital Markets Starts WageWorks (WAGE) at Buy
Nov 30, 2016 06:23AM Chardan Capital Markets Upgrades Arbutus Biopharma (ABUS) to Buy Amid Arrowhead Hepatitis B Program Discontinuations
Nov 30, 2016 06:19AM Chardan Capital Markets Downgrades Arrowhead Research (ARWR) to Neutral on EX-1 RNAi Program Discontinuations
Nov 29, 2016 09:07AM Vuzix Corp. (VUZI) to Offer 2M Shares of Common Stock for Proceeds of $14.5M
Nov 29, 2016 09:00AM Vuzix Announces $14,500,000 Common Stock Offering
Nov 29, 2016 08:31AM Chardan Capital Markets Raises Price Target on Amicus Therapeutics (FOLD); Reiterates Buy
Nov 17, 2016 08:52AM Chardan Capital Markets Remains Bullish on Vuzix Corp. (VUZI) as Intel Steps Back Relationship
Nov 16, 2016 10:49AM Notable Analyst Rating Changes 11/16: (DIS) (FOSL) (PAAS) Upgraded; (NOK) (WDR) (NE) Downgraded
Nov 16, 2016 06:15AM Chardan Capital Markets Starts Teladoc (TDOC) at Buy; Sees 40% Upside
Nov 15, 2016 09:51AM uniQure (QURE) PT Cut to $12 at Chardan Capital Markets; 'Buy' Maintained on Simplification
View More Recent Stories View Older Stories